Loading
AtaiBeckley Inc. Stock: price and insider trades · United States
Insider Decl.
32
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€1M
6 ops. · all time
Who traded when
BuySaleKevin James Craig3 sales
Feilding-Mellen Cosmo1 sale
Gerd Kochendoerfer1 sale
Robert Hershberg1 sale
Analyst consensus: bullish or bearish?
Analysts rate AtaiBeckley Inc. Hold (neutral), based on 6 analysts. Average price target: US$8.12.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$7.35
Analyst consensus
6 analystsHold
US$7.45Target US$8.12(+10%)US$9.25
Income statement
RevenueUS$4.1M
EBITDA-US$657.7M-16084% margin
Net income-US$660M-16142.0% margin
Valuation
PER (forward)-15.3x
P/Book15.4x
Beta1.55
Balance sheet & cash
Market capUS$2.7B
Total debtUS$2.1M
Free Cash Flow-US$113.5M
Debt / Equity2%
Profitability & ownership
ROE-417.2%
ROA-39.0%
% insiders2.2%
% institutions52.3%
Last declaration on 11 September 2026
Declarations32 total
559,232 sharesCommon StockSEC:0001140361-26-036377:0
53,398,214 sharesCommon StockSEC:0001140361-26-036377:1
1,799,302 sharesCommon StockSEC:0001140361-26-036377:2
4,666 sharesCommon StockSEC:0001140361-26-036381:0
4,666 sharesCommon StockSEC:0001140361-26-036382:0
42,333 sharesCommon StockSEC:0001140361-26-036386:0
155,066 sharesCommon StockSEC:0001140361-26-036387:0
140,045 sharesCommon StockSEC:0001140361-26-036388:0
212,942 sharesCommon StockSEC:0001140361-26-036389:0
3,500 sharesCommon StockSEC:0001140361-26-036389:1
8,437 sharesCommon StockSEC:0001140361-26-036390:0
48,858 shares@ US$1.350.0024% mcap10.5% of flowCommon StockSEC:0001140361-26-028137:0
51,142 shares@ US$1.350.0025% mcap10.9% of flowCommon StockSEC:0001140361-26-028137:1
100,000 shares@ US$4.960.018% mcap78.6% of flowCommon StockSEC:0001140361-26-028137:2
100,000 shares@ US$4.960.018% mcap100.0% of flowCommonSEC144:0001950047-26-006940
50,000 shares@ US$5.00100.0% of flowCommon StockSEC:0001140361-26-026786:1
50,000 sharesCommon StockSEC:0001140361-26-026786:0
33,051 sharesCommon StockSEC:0001140361-26-026787:0
42,579 shares@ US$4.5120.5% of flowCommon StockSEC:0001140361-26-026787:2
9,528 sharesCommon StockSEC:0001140361-26-026787:1
50,000 shares@ US$4.58100.0% of flowCommonSEC144:0001950047-26-006539
85,158 shares@ US$4.170.014% mcap100.0% of flowCommonSEC144:0001950047-26-006513
27,280 shares@ US$1.500.0015% mcap5.3% of flowCommon StockSEC:0001140361-26-016169:0
15,299 shares@ US$1.840.0010% mcap3.7% of flowCommon StockSEC:0001140361-26-016169:1
42,579 shares@ US$5.000.0079% mcap27.6% of flowCommon StockSEC:0001140361-26-016169:2
25 of 32 declarations
About AtaiBeckley Inc.
The AtaiBeckley Inc. record sits within the year 2026: 32 filings from 14 filers, published between January 6 and September 11, 2026, with no purchase at all. It holds 6 sales worth EUR 1,441,075 (median EUR 200,348), 12 option exercises and 14 filings of another kind.
The three largest sales are by Robert Hershberg (Director), EUR 433,355 on July 7, 2026, Kevin James Craig (Chief Medical Officer), EUR 306,628 on March 20, 2026, and Gerd Kochendoerfer (Chief Operating Officer), EUR 220,038 on June 26, 2026. Kevin James Craig is the most frequent filer, with 10 filings, 3 of them sales. Christian Angermayer (Director) files 6, with no purchase or sale.
Read moreShow less
This US healthcare and pharma company has a market capitalisation of USD 2.73 billion, and insiders hold 2.2% of it. Because the whole record falls within the last twelve months, it offers no year-on-year comparison. Filings appear a median of 2 days after the trade.
